And finally, as it relates to returning capital to shareholders, we have a long-standing track record of paying dividend for 91 consecutive years and recently grew the dividend for the 14th consecutive year. We remain committed to growing the dividend, subject to Board approval and continue to ...
The Dividend History page provides a single page to review all of the aggregated Dividend payment information.Historical information is not adjusted for stock splits.Visit ourDividend Calendar: Please note that the dividend history for Nasdaq stocks may also be combined the regular with the special ...
Last Dividend Ex-DateJan 03, 2025 Dividend Yield4.02% Share Statistics EPS (TTM)-3.60 Shares Outstanding2,028,176,600 10 Day Avg. Volume9,576,052 30 Day Avg. Volume10,975,610 Standard Deviation0.06 R-Squared0.14 Alpha-0.00233 Financial Highlights & Ratios PEG RatioN/A Price to Book (P/...
potential for strong revenue growth of their therapeutics and low dividend payout ratio could make bristol-myers squibb an appealing dividend investment. source finances one of the first things that stands out with bristol-myers squibb is the slow growth of their finances over the last 20 years....
Check your account Annual meeting of shareholders Learn more You may complete the following transactions online athttp://www.shareowneronline.com: Change address Purchase more shares for as little as $50 or as much as $10,000 Get dividend information ...
Valuation and Your Takeaway BMY stock has upside of 35% if income investors use adividend discount modelto value the company. Assuming modest perpetuity growth of just 2.7% – 3.7%, the stock clearly trades at a discount. Investors are punishing the company more than they need to. If the ...
IPO Date 2011-08-30 Description Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to ...
Dividend Yield (TTM) 6.29% Annual Payout (TTM) $0.51 Payout Ratio - 5 Year Growth Rate (CAGR) 4.67% Years of Growth 2 Years Latest Announced Dividend $0.11 Ex-Dividend Date 12/4/2024 Payout Date 12/12/2024 Frequency Annual More On Dividends » ...
At the end of it all, I would say we need to wait to see the data in the Phase 3 trial for the competitor molecule. We already have our Phase 3 data. We've already submitted and look forward to bringing it to patients with a ...
We've continued our commitment to our dividend and investing in future innovation through business development. So now let's turn to Slide 16 and review the guidance. Last quarter, we provided assumptions around how we view the impact of COVID-19 crisis on our business. Our view today h...